Skip to content

Hypothermia for Encephalopathy in Low Income Countries-Feasibilty

Hypothermia for Encephalopathy in Low Income Countries-Feasibility

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01760629
Acronym
HELIX-I
Enrollment
62
Registered
2013-01-04
Start date
2013-04-30
Completion date
2014-12-31
Last updated
2015-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Encephalopathy

Keywords

Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia

Brief summary

Whole body cooling improves survival with normal neurological outcome after neonatal encephalopathy in high-income countries. However, cooling equipments used in the high-income countries are expensive and unsuitable for wider use in low and middle-income countries (LMIC). We had previously conducted a randomised controlled trial of whole body cooling using phase changing material in south India. Although cooling was provided, there were wide temperature fluctuations. Aim: To examine efficacy of the low technology cooling equipment (Tecotherm-HELIX) in administering effective and stable whole body cooling in encephalopathic infants. Methods: After informed parental consent (and ethical approvals), we will administer 72 hours of whole body cooling (rectal temperature 33 to 34C) to a total 50 encephalopathic infants (aged \<6 hours) admitted to the neonatal units at Calicut Medical College and Madras Medical College, over a six month period. To induce cooling, the infants will be kept on the cooling mattress. Temperature will be continuously measured for 80 hours using a rectal probe connected to a digital data logger. The primary outcome will be the effective cooling time i.e. percentage of time (95% CI) for which the temperature remains between 33 to 340C during the intended cooling period.

Interventions

DEVICETecotherm-HELIX

Whole body cooling using Tecotherm-HELIX

Sponsors

Government Medical College, Kozhikode
CollaboratorOTHER
Institute for Child Health, Madras Medical College, Egmore, Chennai
CollaboratorUNKNOWN
Wayne State University
CollaboratorOTHER
Manipal Hospital, India
CollaboratorOTHER
Thayyil, Sudhin
Lead SponsorINDIV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 1 Months
Healthy volunteers
No

Inclusion criteria

1. Age \< 6 hours, Birth-weight \>1.8, Gestation \>36 weeks 2. Need for resuscitation at birth and 5 minute Apgar score \<6 (in born babies) or Lack of cry by 5 minutes of age (for out-born babies) 3. Evidence of encephalopathy on clinical examination

Exclusion criteria

* Infants in moribound condition, where death is imminent * Absent heart rate at 10 minute of age * Major life threatening congenital malformation * Lack of cooling equipment * Lack of parental or physician consent

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of cooling72 hoursTo examine feasibility of whole body cooling within six hours of birth in infants with neonatal encephalopathy

Secondary

MeasureTime frameDescription
Short term morbidity2 weeksShort-term neonatal morbidity - Hypotension requiring inotropes, cardiac arrhythmias (other than bradycardia), coagulopathy/thrombocytopenia requiring blood products, respiratory failure requiring ventilatory support, seizures, and subcutaneous fat necrosis.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026